Dr David Austin’s recent publications
2024
Austin, D. et al. (2024) ‘Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial’, JACC:CardioOncology, ePub:August. Doi: 10.1016/j.jaccao.2024.07.010
Kunadian, V. et al. (2024) ‘Invasive Treatment Strategy for Older Patients with Myocardial Infarction’, The New England Journal of Medicine, ePub:September. Doi: 10.1056/NEJMoa2407791.
2023
James, S. et al. (ePub2023) ‘Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure’, NEJM Evidence, 2024:3(2). Doi: 10.1056/EVIDoa2300286.
Jeyalan, V. et al. (2023) ‘Fractalkine/CX3CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?’ Cells, 12(19). Doi: 10.3390/cells12192377
van den Broek, WWA. et al. (2023) ‘Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry’, Journal of Clinical Medicine, 12(17). Doi: 10.3390/jcm12175450.
Burgoine, T. et al. (ePub2023) ‘Automated external defibrillator location and socioeconomic deprivation in Great Britain’, Heart, 2024:110(3), p188-194. Doi: 10.1136/heartjnl-2023-322985
Loh, S. et al. (2023) ‘Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease’, Journal of Clinical Medicine,12(14). Doi: 10.3390/jcm12144821
Bawamia, B. et al. (2023) ‘Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction’, Geroscience, 45(4). Doi: 10.1007/s11357-023-00794-6
2022
Maier RH. et al. (2022) ‘Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT)’, BMJ Open, 12(12). Doi: 10.1136/bmjopen-2022-066252.
Doolub, G. et al. (ePub2022) ‘Impact of Sex on Clinical Outcomes in Patients undergoing Complex Percutaneous Coronary Angioplasty (from the e-ULTIMASTER Study)’, American Journal of Cardiology. 2023:1(186), p71-79. Doi: 10.1016/j.amjcard.2022.10.023.
Saada, M. et al. (2022) ‘Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry’, Clinical Cardiology, 45(12), p1211-1219. Doi: 10.1002/clc.23902.
Razvi, S. et al. (2022) ‘Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction’, European Thyroid Journal, (2). Doi: 10.1530/ETJ-21-0085
Telyuk P. et al. (2022) ‘Lipoprotein(a): Insights for the Practicing Clinician’, Journal of Clinical Medicine, 11(13). Doi: 10.3390/jcm11133673
Vahabi, S. et al. (2022) ‘Right ventricular mechanics in anthracycline chemotherapy: insights into the PROACT PLUS study’, European Heart Journal – Cardiovascular Imaging, 23(1). Doi: 10.1093/ehjci/jeab289.418
Vahabi, S. et al.(2022) ‘Atrial mechanics in anthracycline chemotherapy: insights into a prospective study’, European Heart Journal – Cardiovascular Imaging, 23(1). Doi: 10.1093/ehjci/jeab289.027
Vahabi, S. et al. (2022) ‘Anthracycline chemotherapy and its effects on left ventricular mechanics: insights into the PROACT PLUS study, European Heart Journal – Cardiovascular Imaging, 23(1). Doi: 10.1093/ehjci/jeab289.026
2021
Jabbar, A. et al. (2021) ‘Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study, Journal of Endocrinological Investigation, 44 p.1209–1218. Doi: 10.1007/s40618-020-01408-0
2020
Vahabi, S. et al. (2020) ‘The effects of doxorubicin on left and right atrial mechanics in patients with lymphoma, European Heart Journal, 41(2). Doi: 10.1093/ehjci/ehaa946.3284
Maier, R. et al. (2020) ‘Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial’, JMIR Research Protocols, 9(9). Doi: 10.2196/19456
Jabbar, A. et al. (2020) ‘Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial’, JAMA The Journal of the American Medical Association, 324(3), p.249-258. Doi: 10.1001/jama.2020.9389
Bawamia, BR. et al. (2020) ‘Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality’, Catheterization and Cardiovascular Interventions, 96(4):E416-E422. Doi: 10.1002/ccd.28818